Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q96T51
UPID:
RUFY1_HUMAN
Alternative names:
FYVE-finger protein EIP1; La-binding protein 1; Rab4-interacting protein; Zinc finger FYVE domain-containing protein 12
Alternative UPACC:
Q96T51; Q59FF3; Q71S93; Q9H6I3
Background:
RUN and FYVE domain-containing protein 1, known by alternative names such as FYVE-finger protein EIP1, La-binding protein 1, Rab4-interacting protein, and Zinc finger FYVE domain-containing protein 12, plays a crucial role in cellular processes. It binds phospholipid vesicles containing phosphatidylinositol 3-phosphate and is instrumental in early endosomal trafficking. This protein's unique ability to interact with specific phospholipids underlines its significance in intracellular signaling and trafficking pathways.
Therapeutic significance:
Understanding the role of RUN and FYVE domain-containing protein 1 could open doors to potential therapeutic strategies. Its involvement in endosomal trafficking suggests a pivotal role in cellular homeostasis and signaling, making it a compelling target for drug discovery efforts aimed at modulating intracellular transport mechanisms.